Konstantin Andreev

7PUBLICATIONS
17CO-AUTHORS
Animal protection (incl. pests and pathogens)Animal growth and developmentMedical infection agents (incl. prions)Phylogeny and comparative analysisColloid and surface chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 19, 2026
Baloxavir outperforms oseltamivir, favipiravir, and amantadine in treating lethal influenza A(H5N1) HA clade 2.3.4.4b infection in mice.

Konstantin Andreev, Jeremy C Jones, Ahmed Kandeil

|Feb 18, 2026
Baloxavir alleviates severe disease and viremia in ferrets infected with avian- or bovine-origin influenza A(H5N1) virus.

Jeremy C Jones, Konstantin Andreev, Vyoma Sheth

|Jul 22, 2025
Genotype B3.13 influenza A(H5N1) viruses isolated from dairy cattle demonstrate high virulence in laboratory models, but retain avian virus-like properties.

Thomas P Fabrizio, Ahmed Kandeil, Walter N Harrington

|Mar 28, 2025
Publisher Correction: Baloxavir improves disease outcomes in mice after intranasal or ocular infection with Influenza A virus H5N1-contaminated cow's milk.

Jeremy C Jones, Konstantin Andreev, Thomas P Fabrizio

|Mar 18, 2025
Baloxavir improves disease outcomes in mice after intranasal or ocular infection with Influenza A virus H5N1-contaminated cow's milk.

Jeremy C Jones, Konstantin Andreev, Thomas P Fabrizio

|Sep 28, 2023
Antiviral Susceptibility of Highly Pathogenic Avian Influenza A(H5N1) Viruses Circulating Globally in 2022-2023.

Konstantin Andreev, Jeremy C Jones, Patrick Seiler

Pageof 2

Frequent Collaborators

6 joint publications

Jeremy C Jones

6 joint publications

Elena A Govorkova

5 joint publications

Richard J Webby

3 joint publications

Andrew S Bowman